Clinicopathological parameters (age, sex, tumor diameter, differentiation, TNM stage, thyroid exocapsular invasion, lymph node metastasis) and serum SLC31A1 levels (measured via ELISA) were analyzed. This evidence concerns the gene SLC31A1 and metastatic malignant neoplasm in the lymph nodes.